Risk-adapted strategies for the treatment of Hodgkin lymphoma.

about

Risk-adapted strategies for the treatment of Hodgkin lymphoma.

Item

http://www.wikidata.org/entity/Q38591137

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Risk-adapted strategies for the treatment of Hodgkin lymphoma.

@en

type

Item

label

Risk-adapted strategies for the treatment of Hodgkin lymphoma.

@en

prefLabel

Risk-adapted strategies for the treatment of Hodgkin lymphoma.

@en

P1476

Risk-adapted strategies for the treatment of Hodgkin lymphoma.

@en

P2093

Jesse Keller

http://www.w3.org/2001/XMLSchema#string

Kenneth R Carson

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD

Treatment of stage I and II Hodgkin's lymphoma with ABVD chemotherapy: results after 7 years of a prospective study

Dose-Intensification in Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial

Cancer statistics, 2009

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

Treatment selection and outcomes in early-stage classical Hodgkin lymphoma: analysis of the National Cancer Data Base.

Combined modality treatment improves tumor control and overall survival in patients with early stage Hodgkin's lymphoma: a systematic review.

Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation study.

Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's

Panobinostat in patients with relapsed/refractory Hodgkin's lymphoma after autologous stem-cell transplantation: results of a phase II study.

P304

1519-1530

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14740338.2015.1084285

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26394771

http://www.w3.org/2001/XMLSchema#string

Risk-adapted strategies for the treatment of Hodgkin lymphoma.

about

Risk-adapted strategies for the treatment of Hodgkin lymphoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698